ACOR

Acorda Therapeutics
ACOR

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

16 hedge funds and large institutions have $2.3M invested in Acorda Therapeutics in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

Holders
16
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$48K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$161K
2
+$7.49K
3
+$2.01K
4
TRCT
Tower Research Capital (TRC)
New York
+$495
5
BlackRock
BlackRock
New York
+$30

Top Sellers

1
-$6.39K
2
-$2.65K
3
-$1.5K
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$13
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$750K
2
$690K
3
$489K
4
$161K
5
$102K
6
$56.1K
7
$25.5K
8
$17.6K
9
$4.37K
10
$2.01K
11
$615
12
$44
13
$29
14
$29
15
$15
16
–
17
–